BioMaxima Market Cap

BioMaxima has a market cap or net worth of 40.59 million as of June 16, 2026. Its market cap has decreased by -33.92% in one year.

Market Cap

40.59M

Enterprise Value

55.44M

Revenue

60.90M

Ranking

n/a

PE Ratio

386.57

Stock Price

9.58

Market Cap Chart

Since July 21, 2010, BioMaxima's market cap has increased from 11.40M to 40.59M, an increase of 255.93%. That is a compound annual growth rate of 8.31%.

Market Cap History

Date	Market Cap	% Change
Jun 12, 2026	39.83M	-21.16%
Dec 30, 2025	50.53M	12.62%
Dec 30, 2024	44.87M	-34.84%
Dec 29, 2023	68.85M	-35.28%
Dec 30, 2022	106.38M	-6.37%
Dec 30, 2021	113.62M	-4.71%
Dec 30, 2020	Upgrade Pro	Upgrade Pro
Dec 30, 2019	Upgrade Pro	Upgrade Pro
Dec 27, 2018	Upgrade Pro	Upgrade Pro
Dec 29, 2017	Upgrade Pro	Upgrade Pro
Dec 30, 2016	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Diagnostyka	5.99B
NEUCA	3.24B
Synektik Spólka Akcyjna	2.50B
Voxel	1.24B
Read-Gene	58.71M
Milton Essex Spólka Akcyjna	51.41M
Sygnis	40.32M
Pharmena	34.97M

Market Cap Rankings